126 related articles for article (PubMed ID: 2898287)
21. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin).
Ganapathi R; Hercbergs A; Grabowski D; Ford J
Cancer Res; 1993 Jul; 53(14):3262-5. PubMed ID: 8100737
[TBL] [Abstract][Full Text] [Related]
22. Expression of the P-glycoprotein gene in multidrug-resistant Chinese hamster ovary cells.
Mukhopadhyay T; Kuo MT
Anticancer Res; 1989; 9(3):575-8. PubMed ID: 2569855
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein.
Staats J; Marquardt D; Center MS
J Biol Chem; 1990 Mar; 265(7):4084-90. PubMed ID: 1968066
[TBL] [Abstract][Full Text] [Related]
24. A phosphoglycoprotein associated with taxol resistance in J774.2 cells.
Roy SN; Horwitz SB
Cancer Res; 1985 Aug; 45(8):3856-63. PubMed ID: 2861892
[TBL] [Abstract][Full Text] [Related]
25. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
Yang JM; Goldenberg S; Gottesman MM; Hait WN
Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
[TBL] [Abstract][Full Text] [Related]
27. Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells.
Warr JR; Anderson M; Fergusson J
Cancer Res; 1988 Aug; 48(16):4477-83. PubMed ID: 2899455
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
29. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
Breier A; Stefanková Z; Barancík M; Tribulová N
Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a K562 multidrug-resistant cell line.
Yanovich S; Hall RE; Gewirtz DA
Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171
[TBL] [Abstract][Full Text] [Related]
31. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.
Sugawara I; Kataoka I; Morishita Y; Hamada H; Tsuruo T; Itoyama S; Mori S
Cancer Res; 1988 Apr; 48(7):1926-9. PubMed ID: 2894894
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance.
Gerlach JH; Kartner N; Bell DR; Ling V
Cancer Surv; 1986; 5(1):25-46. PubMed ID: 2885085
[TBL] [Abstract][Full Text] [Related]
33. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
Nare B; Prichard RK; Georges E
Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
[TBL] [Abstract][Full Text] [Related]
34. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R
Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771
[TBL] [Abstract][Full Text] [Related]
35. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
36. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP
Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687
[TBL] [Abstract][Full Text] [Related]
37. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
38. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
39. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein.
Poleková L; Barancík M; Mrázová T; Pirker R; Wallner J; Sulová Z; Breier A
Neoplasma; 1992; 39(2):73-7. PubMed ID: 1356238
[TBL] [Abstract][Full Text] [Related]
40. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine.
Ma LD; Marquardt D; Takemoto L; Center MS
J Biol Chem; 1991 Mar; 266(9):5593-9. PubMed ID: 1672314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
